STIM Neuronetics Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: STIM

Price (delayed)

$2.88

Market cap

$219.45M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.44

Enterprise value

$281.02M

?
Relative Growth: Rel. Growth: 85
Relative Strength: Rel. Strength: 97
Relative Valuation: Rel. Valuation: 24
Relative Profitability: Rel. Profitability: 29

Neuronetics, Inc. believes that mental health is as important as physical health. As a global leader in neuroscience and the largest TMS company in the industry, Neuronetics is redefining patient ...

Highlights
STIM's EPS has soared by 61% YoY and by 19% from the previous quarter
The revenue has grown by 40% YoY and by 2.3% from the previous quarter
STIM's equity is up by 35% since the previous quarter but it is down by 34% year-on-year
Neuronetics's quick ratio has increased by 17% from the previous quarter but it has decreased by 8% YoY
The company's debt rose by 7% YoY
Sector: Healthcare
Industry: Diagnostics & Research
Website: http://www.neurostar.com
Peers: OBIO OM

Key stats

What are the main financial stats of STIM

STIM stock price

How has the Neuronetics stock price performed over time
Intraday
-1.03%
1 week
4.35%
1 month
-4%
1 year
4.73%
YTD
108.7%
QTD
121.54%

Financial performance

How have Neuronetics's revenue and profit performed over time
Revenue
$155.1M
Gross profit
$76.19M
Operating income
-$22.86M
Net income
-$30.43M
Gross margin
49.1%
Net margin
-19.6%
The company's operating margin has surged by 57% YoY and by 24% QoQ
The company's net margin has surged by 55% YoY and by 20% QoQ
The revenue has grown by 40% YoY and by 2.3% from the previous quarter
STIM's operating income is up by 40% YoY and by 22% from the previous quarter

Price vs fundamentals

How does STIM's price correlate with its fundamentals

Growth

What is Neuronetics's growth rate over time

Valuation

What is Neuronetics stock price valuation
P/E
N/A
P/B
11.23
P/S
1.36
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.81
STIM's EPS has soared by 61% YoY and by 19% from the previous quarter
STIM's price to book (P/B) is 96% more than its last 4 quarters average of 5.8
STIM's equity is up by 35% since the previous quarter but it is down by 34% year-on-year
The P/S is 71% above the last 4 quarters average of 0.8 but 2.1% below the 5-year quarterly average of 1.4
The revenue has grown by 40% YoY and by 2.3% from the previous quarter

Efficiency

How efficient is Neuronetics business performance
STIM's ROS has soared by 63% YoY and by 26% from the previous quarter
STIM's ROIC is up by 49% YoY and by 23% from the previous quarter
The return on assets has increased by 44% year-on-year and by 17% since the previous quarter
The ROE has grown by 23% YoY and by 9% from the previous quarter

Dividends

What is STIM's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for STIM.

Financial health

How did Neuronetics financials performed over time
The total assets is 20% more than the total liabilities
Neuronetics's quick ratio has increased by 17% from the previous quarter but it has decreased by 8% YoY
STIM's current ratio is up by 13% from the previous quarter but it is down by 7% YoY
STIM's debt to equity has soared by 63% YoY but it is down by 25% QoQ
STIM's equity is up by 35% since the previous quarter but it is down by 34% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.